AzurRx BioPharma Inc (AZRX)


Stock Price Forecast

Oct. 21, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading AzurRx BioPharma Inc chart...

About the Company

We do not have any company description for AzurRx BioPharma Inc at the moment.

Exchange

NASDAQ

$214M

Total Revenue

12

Employees

$15M

Market Capitalization

-0.21

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AZRX News

Biopharma company to create 401 jobs in Wilson

13h ago, source: WRAL on MSN

The jobs would be part of a $317 million investment in the county. The announcement came during a meeting of the state ...

3 Biopharma Stocks You Don't Want to Miss in the New Bull Market

13d ago, source: Nasdaq

The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in ...

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript

11d ago, source: Hosted on MSN

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript March 6, 2024 Xeris Biopharma Holdings, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the ...

Xeris Biopharma: Q4 Earnings Snapshot

12d ago, source:

CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Wednesday reported a loss of $13.4 million in its fourth quarter. The Chicago-based company said it had a loss of 10 cents per ...

Biopharma Stock News Bite - Geron Corporation (Nasdaq: GERN) Makes NASDAQ Top Gainers List on FDA News

3d ago, source: Investor ideas

Investorideas.com ( Biotech Stock News Bites - Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...